Showing results (1951-1960 of 3,086) with videos related to
Sort By:
Pageof 309
Drug Safety|May 3, 2007
Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in EnglandBeverley R Twaites, Lynda V Wilton, Saad A W ShakirDrug Safety|June 1, 2007
Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literatureLeonard C Hawkins, John N Edwards, Paul I DarganDrug Safety|June 1, 2007
Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibaseI Ralph Edwards, Kristina Star, Anne KiuruDrug Safety|July 1, 2006
Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?Wolfgang Aichhorn, Alexandra B Whitworth, Elisabeth M Weiss, et al.Drug Safety|July 1, 2006
Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trialsSøren PedersenDrug Safety|May 13, 2006
Effects of maternally administered drugs on the fetal and neonatal kidneyFarid Boubred, Mariella Vendemmia, Patricia Garcia-Meric, et al.Drug Safety|May 13, 2006
Overcoming 'ageism' bias in the treatment of hypercholesterolaemia : a review of safety issues with statins in the elderlyTerry A JacobsonDrug Safety|May 13, 2006
Adverse reactions induced by NSAIDs and antibacterials: analysis of spontaneous reports from the Sicilian regional databaseGiovanni Polimeni, Francesco Salvo, Paola Cutroneo, et al.Drug Safety|January 23, 2023
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting SystemMichele Fusaroli, Guido Pelletti, Valentina Giunchi, et al.Drug Safety|December 2, 2022
The Food and Drug Administration's (FDA's) Drug Safety Surveillance During the COVID-19 PandemicIda-Lina Diak, Kimberley Swank, Kate McCartan, et al.Pageof 309